https://www.scinai.com/careers
daily
0.75
2025-01-22
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/107021ee-e063-404c-8eb2-fd67d94c8510/WhatsApp+Image+2022-03-16+at+1.05.51+PM.jpeg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2d044ddd-c0c1-4e72-babb-f66350819b78/image-asset.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/79ec2952-e438-46d3-9792-bb995799683f/CMC+Support.jpg
https://www.scinai.com/careers/blog-post-title-four-49b2a
monthly
0.5
2024-09-15
https://www.scinai.com/in-the-news
daily
0.75
2025-03-03
https://www.scinai.com/in-the-news/scinai-immunotherapeutics-featured-in-the-marker-labels-biomed-magazine
monthly
0.5
2025-03-03
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2df3d7b0-96f1-42b7-84df-e840c4323483/Articale.png
In The News - Scinai Immunotherapeutics featured in The Marker Labels Biomed Magazine - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/in-the-news/biomed-wire-featuring-amir-recihman-ceo-of-scinai-immunotherapeutics-scni
monthly
0.5
2024-09-22
https://www.scinai.com/in-the-news/smart-money-circle-podcast
monthly
0.5
2024-09-22
https://www.scinai.com/in-the-news/biologics-development-in-immunology-and-inflammation-featuring-amir-reichman-ceo-of-scinai-immunotherapeutics
monthly
0.5
2024-02-29
https://www.scinai.com/in-the-news/no-camels-biopharma-company-sees-success-in-trial-for-psoriasis-jab
monthly
0.5
2023-12-26
https://www.scinai.com/in-the-news/fierce-pharma-biondvax-rebrand-scinai-6sep2023
monthly
0.5
2023-09-07
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2d99919c-1d37-4e63-aff5-156cf7ce659b/Fierce-Pharma-logo
In The News - BiondVax Pharmaceuticals hits branding reset to become Scinai Immunotherapeutics amid a troubled year - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/in-the-news/jnp21l5bvdpminq6hr334knoscg99l
monthly
0.5
2024-01-16
https://www.scinai.com/in-the-news/bell2bell-podcast-featuring-amir-reichman-ceo
monthly
0.5
2023-09-03
https://www.scinai.com/in-the-news/nasdaq-these-are-some-of-the-best-ideas-from-the-bio-europe-spring-conference
monthly
0.5
2023-08-31
https://www.scinai.com/in-the-news/test-optimize-scale-podcast-episode-101-featuring-amir-reichman
monthly
0.5
2023-09-03
https://www.scinai.com/events
daily
0.75
2025-02-24
https://www.scinai.com/events/bio-europe-spring-2025
monthly
0.5
2025-02-24
https://www.scinai.com/events/mixiii-2025
monthly
0.5
2025-02-24
https://www.scinai.com/events/expert-panel-plaque-psoriasis-the-unmet-need-scinais-innovative-solution
monthly
0.5
2024-09-15
https://www.scinai.com/events/hc-wainwright-26th-annual-global-investment-conference
monthly
0.5
2024-08-26
https://www.scinai.com/events/eadv
monthly
0.5
2024-09-15
https://www.scinai.com/events/investor-webinar-q2-financial-results-and-business-update
monthly
0.5
2024-08-13
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/617f35bc-99be-4fe2-98d2-0cb25b21fc44/Scinai_Amir_Q2+Financial+Results_linkedin+event.jpg
Events - Investor Webinar - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/events/bio-europe-1
monthly
0.5
2024-10-27
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/768d774d-3ec0-43df-891f-1f0081612baa/Scinai_BIO-Europe_banner+copy.jpg
Events - BIO-Europe - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/events/bio-europe-spring-1
monthly
0.5
2024-01-23
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9292196c-e4f2-4db0-96b6-8cd638a8b3d2/BIO-Europe+Spring+24_Logo+stacked+color+Dates%403x.png
Events - BIO-Europe Spring - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/events/5th-dermatology-drug-development-summit-europe
monthly
0.5
2024-03-06
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6ded3b33-292f-46eb-a601-3c98426cb448/Tamar+Ben+Yedidia+presenting+at+Dermatology+2024.png
Events - 5th Dermatology Drug Development Summit Europe - Make it stand out
https://dermatology-drugdevelopment-europe.com/
https://www.scinai.com/events/biomed-israel-2024
monthly
0.5
2024-01-23
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/efb0dd40-7723-4da9-8c28-4adbe8a991f0/BIOMED+2024+banner.png
Events - BIOMED Israel 2024 - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/events/mixiii-2023
monthly
0.5
2024-01-23
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4227a5ea-8d81-471b-816a-ca27ce40e207/MIXiii+2023+banner.png
Events - MIXiii 2024 - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/events/lsx-world-congress-usa
monthly
0.5
2023-09-07
https://www.scinai.com/events/hc-wainwright-25th-annual-global-investment-conference
monthly
0.5
2023-09-07
https://www.scinai.com/events/bio-europe
monthly
0.5
2023-09-03
https://www.scinai.com/events/cphi-barcelona
monthly
0.5
2023-09-12
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3ceaa153-4ab0-4282-8d98-f841ed4c1017/CPHI+banner.png
Events - CPHI Barcelona - Make it stand out
Book a meeting with us now
https://www.scinai.com/press-releases
daily
0.75
2025-03-17
https://www.scinai.com/press-releases/bio-europe-spring
monthly
0.5
2025-03-17
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4131e9c3-1cc5-4690-943d-bf203df1374e/BIO-EUROPE+SPRING_PR+copy+%281%29.jpg
Press Release - <span class="sqsrte-text-color--accent">Scinai to Connect with Investors, Showcase its Innovative I&I pipeline and its Boutique cGMP Biologics CDMO during BIO-Europe Spring 2025</span> - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-10-million-standby-equity-purchase-agreement
monthly
0.5
2025-03-05
https://www.scinai.com/press-releases/jpm2025
monthly
0.5
2025-01-06
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/67c198f2-5f96-4cbb-b209-6b4c10e9b76d/linkedin-100+%285%29.jpg
Press Release - Scinai to Connect with Investors and Pharma Leaders at Upcoming Key US Conferences - Make it stand out
Meet Scinai Leaderhsip at Mini Mixii Mayami and JPM Healthcare conferences
https://www.scinai.com/press-releases/scinai-immunotherapeutics-establishes-us-subsidiary-for-cdmo-business-unit-scinai-bioservices-inc
monthly
0.5
2024-12-16
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1734377849067-L54T454VFJMCG73IS7T7/U.S.+Subsidiary.jpg
Press Release - Scinai Immunotherapeutics Establishes U.S. Subsidiary for CDMO Business Unit, Scinai Bioservices Inc. - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/prof-michael-schn-director-of-dermatology-and-venereology-at-the-university-medical-center-gttingen-germany-umg-joins-scinai-immunotherapeutics-scientific-advisory-board
monthly
0.5
2024-12-05
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/fa6daa35-8a5e-4e69-b396-1b619afe9341/Scinai_welcome_Michael.jpg
Press Release - Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), Joins Scinai Immunotherapeutics' Scientific Advisory Board - Make it stand out
Prof. Michael Schön, Director of Dermatology and Venereology at the University Medical Center Göttingen, Germany (UMG), joins Scinai Immunotherapeutics' Scientific Advisory Board
https://www.scinai.com/press-releases/dr-jonathan-sadeh-former-senior-vice-president-of-immunology-rampd-at-bristol-myers-squibb-joins-scinai-immunotherapeutics-scientific-advisory-board
monthly
0.5
2024-11-27
https://www.scinai.com/press-releases/scinai-publishes-financial-results-and-provides-business-update-shareholders-equity-up-from-negative-73-million-as-of-june-30-2024-to-positive-10-million
monthly
0.5
2024-11-22
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1b472890-09c7-468f-b9bf-2e9d2e058e6a/table+1.png
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . BALANCE SHEETS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c92ab807-fa08-466f-9e9c-26052078987f/linkedin+%285%29.jpg
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bd7c2b74-6395-435c-ae6d-880040a90fb6/table+4.png
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . STATEMENTS OF COMPREHENSIVE LOSS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/71282564-49d9-4462-8bc0-43422c7ebe0a/table+6.png
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited). STATEMENTS OF CASH FLOWS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9d39d6e1-acaa-43c2-a7c4-2a162e68f6c7/table+2.png
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . BALANCE SHEETS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6d2a2e04-81bb-43d1-ae36-0b33a9a31304/table+5.png
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited). STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b6b3142d-8eba-40e9-976c-7c5a5114738c/table+3.png
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited) . STATEMENTS OF OPERATIONS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/70e50965-5bd5-43d5-a9c2-a87a9ea4f064/table+7.png
Press Release - Scinai Publishes Financial Results and Provides Business Update; Shareholders' Equity up from negative $7.3 million as of June 30, 2024, to positive $10 million - Make it stand out
SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) – (Unaudited). STATEMENTS OF CASH FLOWS
https://www.scinai.com/press-releases/scinai-leadership-to-showcase-companys-cgmp-biologics-cdmo-and-innovative-iampi-pipeline-during-bio-europe-2024
monthly
0.5
2024-10-31
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/855000ef-22fb-4f26-9071-080c4ee29f80/Scinai_BIO-Europe_banner+copy.jpg
Press Release - Scinai Leadership to Showcase Company’s cGMP Biologics CDMO and Innovative I&I pipeline during BIO-Europe 2024 - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-to-host-online-expert-panel-on-plaque-psoriasis-treatment-and-intralesional-injections-of-anti-il-17af-vhh-antibodies
monthly
0.5
2024-09-16
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4a1adb24-f5df-4bdf-a955-94d0769f6194/X-100.jpg
Press Release - Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH Antibodies - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-regains-full-compliance-with-nasdaq-listing-requirements
monthly
0.5
2024-08-29
https://www.scinai.com/press-releases/scinai-announces-closing-of-loan-restructuring-agreement-with-european-investment-bank-converting-approximately-29-million-of-debt-to-preferred-equity-and-leaving-debt-balance-of-273000-nbsp
monthly
0.5
2024-08-21
https://www.scinai.com/press-releases/scinai-announces-entering-into-2-million-private-equity-commitment-agreement-with-its-largest-existing-shareholder
monthly
0.5
2024-08-20
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d2743046-4f2f-49e6-bf19-87a11618e7a9/Scinai_Amir_Q2%2BFinancial%2BResults_linkedin%2Bevent.jpg
Press Release - Scinai Announces Entering into $2 Million Private Equity Commitment Agreement with its largest Existing Shareholder - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-publishes-q2-2024-financial-results-and-provides-business-update-restructures-29-million-bank-loan-to-equity-andnbspregains-nasdaq-compliance
monthly
0.5
2024-08-15
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/639d7bd3-693f-4bbc-b989-c09d5aad4309/01.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - BALANCE SHEETS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c68c408b-eeb0-4e40-8674-e39a1dc6f187/Scinai_Amir_Q2+Financial+Results_linkedin+event.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/90f764ab-8d4d-4e24-a471-d2a159bf24e4/07+copy.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF CASH FLOWS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2160945d-6fcb-4c39-a135-f8fcfafe2ef0/04+copy.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF COMPREHENSIVE LOSS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/33d7903e-b22d-4558-90e1-8dfe4d6f530a/03+copy.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF OPERATIONS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f13f0dd9-8540-4291-b2ac-adacffeb5583/03+copy.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF OPERATIONS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9334cb57-40c0-4c3b-90d8-16fc7775442f/02+copy.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - BALANCE SHEETS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/433b03a2-828d-47c2-97d6-5110d007ceae/06+copy.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF CASH FLOWS
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f87a7d9a-0eb7-411b-ac86-21311686ffcf/Scinai_new_CDMO_Section-07.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23
Company Contacts Investor Relations | +972 8 930 2529 | ir@scinai.com Business Development | +972 8 930 2529 | bd@scinai.com
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/28fcf004-c2cc-4c9f-abc8-893c0ee9f5bb/05-1+copy.jpg
Press Release - Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to Equity; On Track to Regain Nasdaq Compliance by August 23 - STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
https://www.scinai.com/press-releases/nbspscinai-announces-signing-of-loan-restructuring-agreement-witheuropean-investment-bank-converting-approximately-29-million-of-debt-to-preferred-equity-convertible-into-195-common-equity
monthly
0.5
2024-08-13
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-positive-regulatory-feedback-from-the-pei-on-the-path-for-phase-12a-in-plaque-psoriasis-with-its-anti-il-17-nanoab-1
monthly
0.5
2024-07-31
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-promising-results-in-an-in-vivo-proof-of-concept-psoriatic-human-skin-model
monthly
0.5
2024-10-31
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-receipt-of-an-updated-letter-of-intent-from-the-european-investment-bank-providing-specific-terms-for-conversion-of-its-loan-to-equity
monthly
0.5
2024-07-31
https://www.scinai.com/press-releases/scinai-immunotherapeutics-granted-extension-by-nasdaq-hearing-panel-to-regain-compliance-with-continued-listing-requirements
monthly
0.5
2024-07-28
https://www.scinai.com/press-releases/scinai-publishes-q1-2024-financial-results-and-provides-business-update
monthly
0.5
2024-07-31
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9f1af2b0-c8d8-4129-a682-eccc42313bcd/01+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) BALANCE SHEETS
U.S. dollars in thousands (except share and per share data)
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e12b8dd7-daf0-4a6a-ba43-dbd1272ce0a1/06+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
U.S. dollars in thousands (except share and per share data)
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/89647d23-f2c8-423a-add3-db29a69276ef/07+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CASH FLOWS
U.S. dollars in thousands
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/74d3b87e-bb31-4c08-9208-93e0a150179c/04+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF COMPREHENSIVE LOSS
U.S. dollars in thousands (except share and per share data)
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2d09c87f-c256-441f-a86a-094698f251fe/03+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF OPERATIONS
U.S. dollars in thousands (except share and per share data)
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/543de8eb-18a7-452b-9daf-389ba16a2cfe/02+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) BALANCE SHEETS
U.S. dollars in thousands (except share and per share data)
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/fa12f5dc-d7c4-4ba4-b100-a148d9391276/05+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
U.S. dollars in thousands (except share and per share data)
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/58916d06-1bc5-40f2-9a69-d79ea6981477/08+copy.png
Press Release - Scinai Publishes Q1 2024 Financial Results and Provides Business Update - SCINAI IMMUNOTHERAPEUTICS LTD. (Formerly known as BiondVax Pharmaceuticals Ltd.) STATEMENTS OF CASH FLOWS
U.S. dollars in thousands (except share and per share data)
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-receipt-of-a-letter-of-intent-from-the-european-investment-bank-providing-specific-terms-for-conversion-of-its-loan-to-equity
monthly
0.5
2024-07-09
https://www.scinai.com/press-releases/scinai-immunotherapeutics-regains-compliance-with-nasdaq-minimum-bid-price-requirement-continues-to-work-with-the-european-investment-bank-to-convert-loan-to-equity
monthly
0.5
2024-06-09
https://www.scinai.com/press-releases/scinai-immunotherapeuticsnbspannounces-receipt-of-a-nasdaq-staff-determination-letter-regarding-shareholders-equity-listing-requirements-and-hearing-to-present-a-plan-for-regaining-compliance-1
monthly
0.5
2024-05-24
https://www.scinai.com/press-releases/5la0ftqhjqbf3ovrlt4w732w5ebhs5
monthly
0.5
2024-05-26
https://www.scinai.com/press-releases/scinai-immunotherapeuticsnbspannounces-receipt-of-nasdaq-delisting-notification-and-appeal
monthly
0.5
2024-05-26
https://www.scinai.com/press-releases/scinai-cso-dr-tamar-ben-yedidia-to-present-at-dermatology-drug-development-summit-together-with-prof-michael-schn-of-umg
monthly
0.5
2024-04-11
https://www.scinai.com/press-releases/scinai-immunotherapeutics-cdmo-unit-selected-by-ayana-pharma-to-provide-drug-development-and-cgmp-manufacturing-services
monthly
0.5
2024-04-08
https://www.scinai.com/press-releases/scinai-leadership-to-attend-bio-europe-spring-2024
monthly
0.5
2024-03-12
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f21b7c4a-3e7d-4076-8e97-d1df161d454d/Scinai+at+BIOEuropeSpring+2024+-+for+website+and+social.gif
Press Release - Scinai leadership to attend BIO-Europe Spring 2024 - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-to-showcase-its-cgmp-biologics-cdmo-and-innovative-nanoab-pipeline-at-mixiii-2024
monthly
0.5
2024-02-29
https://www.scinai.com/press-releases/scinai-welcomes-liat-halpert-as-head-of-business-development-and-sales
monthly
0.5
2024-02-13
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1707819696677-BSRV50T3Z8N3LOL32W35/IMG_2881.jpg
Press Release - Scinai Welcomes Liat Halpert as Head of Business Development and Sales - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-immunotherapeutics-congratulates-its-co-lead-scientific-research-collaborator-dirk-grlich-on-louis-jeantet-prize
monthly
0.5
2024-01-25
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1706196140595-7XZ96DDOQ50JS611U0B8/Congratulations+to+Prof.+Dirk+Gorlich.png
Press Release - Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-closing-of-exercise-of-outstanding-warrants-for-169-million-in-gross-proceeds
monthly
0.5
2024-01-04
https://www.scinai.com/press-releases/scinai-immunotherapeutics-ceo-issues-letter-to-shareholders
monthly
0.5
2024-01-04
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7f7be75d-9b76-4a1f-b56b-304ca453abc7/New+Year+2024+CEO+Letter.jpg
Press Release - Scinai Immunotherapeutics CEO Issues Letter to Shareholders - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e1127d70-e5b1-4187-963c-1e65b382996c/HypoSkin+model.png
Press Release - Scinai Immunotherapeutics CEO Issues Letter to Shareholders - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-exercise-of-outstanding-warrants-for-169-million-in-gross-proceeds
monthly
0.5
2024-01-04
https://www.scinai.com/press-releases/scinai-nasdaq-scni-to-host-analyst-and-investor-webinar-on-january-9
monthly
0.5
2023-12-27
https://www.scinai.com/press-releases/scinai-announces-promising-results-in-a-psoriatic-human-skin-model
monthly
0.5
2023-12-12
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e1127d70-e5b1-4187-963c-1e65b382996c/HypoSkin+model.png
Press Release - Scinai Announces Promising Results in a Psoriatic Human Skin Model - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/study-published-in-antiviral-research-supports-promise-of-scinai-immunotherapeutics-coronavirus-nanoab-as-aerosolized-prophylactic-and-therapeutic-drug
monthly
0.5
2023-12-11
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a7bbac6a-1113-4f9a-91a5-fae056f73a1c/Antiviral+Research+journal+cover+image+Sept+2023.jpg
Press Release - Study published in Antiviral Research supports promise of Scinai Immunotherapeutics’ coronavirus NanoAb as aerosolized prophylactic and therapeutic drug - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/european-investment-bank-eib-extends-maturity-of-its-finance-facility-with-scinai-immunotherapeutics-from-2027-to-2031
monthly
0.5
2023-11-29
https://www.scinai.com/press-releases/scinai-immunotherapeutics-regains-compliance-with-nasdaqs-stockholders-equity-rule
monthly
0.5
2023-11-20
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-award-of-non-dilutive-grant-from-israel-innovation-authority-supporting-its-new-cdmo-business-unit
monthly
0.5
2023-11-20
https://www.scinai.com/press-releases/scinai-immunotherapeutics-provides-update-regarding-nasdaq-compliance
monthly
0.5
2023-11-03
https://www.scinai.com/press-releases/european-investment-bank-eib-considering-extending-maturity-of-its-financial-facility-contract-with-scinai-immunotherapeutics-in-light-of-scinais-recent-strategic-pivot
monthly
0.5
2023-10-31
https://www.scinai.com/press-releases/scinai-reports-third-quarter-2023-financial-results-and-provides-business-update
monthly
0.5
2023-10-31
https://www.scinai.com/press-releases/scinai-immunotherapeutics-to-attend-bio-europe-munich-2023
monthly
0.5
2023-10-30
https://www.scinai.com/press-releases/scinai-immunotherapeutics-to-showcase-its-end-to-end-cgmp-biologics-cdmo-services-at-cphi-barcelona-2023
monthly
0.5
2023-10-04
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-closing-of-133-million-registered-direct-offering
monthly
0.5
2023-09-19
https://www.scinai.com/press-releases/scinai-immunotherapeutics-announces-133-million-registered-direct-offering
monthly
0.5
2023-09-15
https://www.scinai.com/press-releases/scinai-immunotherapeutics-innovative-plaque-psoriasis-treatment-shows-encouraging-preclinical-results
monthly
0.5
2023-09-14
https://www.scinai.com/press-releases/scinai-immunotherapeutics-ltd-to-participate-this-week-in-hc-wainwright-25th-annual-global-investment-conference-in-new-york-and-lsx-usa-congress-2023-in-boston
monthly
0.5
2023-09-11
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1694082778747-NYPGN56SL6I1U0BWJAY4/LSX+World+Congress+USA+2x1.jpg
Press Release - Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1694082925187-D4X5SDL53OSP5IAAI472/HC-Wainwright-logo-2x1.jpg
Press Release - Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston
https://www.scinai.com/press-releases/biondvax-pharmaceuticals-ltd-rebrands-as-scinai-immunotherapeutics-ltd-to-reflect-new-focus-on-development-of-novel-inflammation-and-immunology-iampi-biological-therapeutics
monthly
0.5
2023-10-04
https://www.scinai.com/press-releases/11august2023
monthly
0.5
2023-09-03
https://www.scinai.com/press-releases/1august2023
monthly
0.5
2023-09-03
https://www.scinai.com/press-releases/5june2023
monthly
0.5
2023-09-03
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/0f6aa048-9469-425e-8860-2775d6718f5f/post3.PNG
Press Release - BiondVax signs exclusive license agreement for development and commercialization of a novel anti-IL-17 antibody for treatment of autoimmune and inflammatory diseases including psoriasis - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/15may2023
monthly
0.5
2023-09-03
https://www.scinai.com/press-releases/17april2023
monthly
0.5
2023-09-03
https://www.scinai.com/press-releases/16mar2023
monthly
0.5
2023-09-03
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/eebc892d-3e83-409e-8926-7d5fd5ac5ef1/Capture.PNG
Press Release - BiondVax to Present at BIO-Europe Spring - Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
https://www.scinai.com/press-releases/2february2023
monthly
0.5
2023-09-03
https://www.scinai.com/press-releases/23january2023
monthly
0.5
2023-09-03
https://www.scinai.com/press-releases/6january2023
monthly
0.5
2023-09-03
https://www.scinai.com/press-releases/5january2023
monthly
0.5
2023-09-03
https://www.scinai.com/scinai-immunotherapeutics
daily
0.75
2023-09-05
https://www.scinai.com/nanoabs
daily
0.75
2024-07-01
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a75182e1-e001-4f34-b9cd-67942502cf9c/Alpaca+VHH+Ab+cartoon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/46b47027-4626-473a-b91d-a89ccf5ef079/Human+mAb+cartoon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/81742fd2-c250-4d8e-b622-819ab5a1f19c/Icon%2B-%2BRandD.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e24ef9be-347b-4f31-aff8-a13959903501/Icon%2B-%2BProduct%2BNanoAb.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7c0977a0-51fd-456b-b360-5ae85e933bca/Icon%2B-%2BPatientSafetyandCompliance.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/dda4945c-42ad-4ea1-8ab7-d79b9f022596/Icon%2B-%2BManufacturing.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/5d669ff7-4e99-4c2c-b4b4-84bd695c8bbb/rsz_1matthias_dobbelstein.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/33167f7b-1015-4631-bf7d-05d4bdf2f15c/Dirk+Goerlich.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2325c493-43b0-4961-8fb1-937587cad9d7/embj.v40.19.cover.jpg
https://www.scinai.com/pipeline
daily
0.75
2024-07-16
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/cbd43639-fb1e-4889-8a83-5c81ea8127d8/pipeline.png
https://www.scinai.com/team
daily
0.75
2025-03-20
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/04478202-e04d-4e57-88f8-016240c84536/Dalit%2BWeinstein%2BFischer.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/be79bd07-d2c2-4da7-b03d-ffa274e4ffb6/PHOTO-2024-06-20-10-08-41Tehila.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/27387ebf-e42e-4979-94e6-dc57e99d5290/Merav+Kamensky+-+sq.JPG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e990922f-38ae-42dc-9a4e-44675966b557/Naama+Adi+Hen.JPG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/292585a3-bd7c-4072-a1c2-a4e216f9c8ea/Amir+Reichman.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ad085348-d38a-4cae-9905-464e44ec0e2c/Tamar+Ben-Yedidia.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/11f64a8d-a4df-4532-b558-f9e67ad3837b/Elad+Mark.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b37be300-a9e4-4fc1-983c-2c527cc321f9/IMG_6049.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6395238f-0396-4f0a-8de8-fe39f04089c2/Oded+Ovadia.JPG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e1d84508-0880-4604-90a0-20a308d0d976/Uri+-+lab+bckgrnd.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ed480d6e-480c-4b25-b9c0-66183aded806/Alona+Tal.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6dcc207c-ef55-4ffb-ac2f-c4843ba33ad8/Yael+Marolin.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/06d57f9d-dcb7-458a-b629-48ec817bc8fd/Adi+Raviv+-+BiondVax_opt.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/41a75c69-c44c-44f5-9841-ff89da6d1ffa/Jay+Green%2C+member+of+BiondVax%27s+Board+of+Directors_150x213.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/77cd5f37-e9c3-4100-ace0-025b13fa678a/Morris+Laster_150x213.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4136896e-8480-4cec-8725-b2e14a4b203a/amir.PNG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ddfbfd59-c226-4bfe-b537-3f9259e38140/Mark+Germain%2C+BiondVax+Chairman+of+the+Board+of+Directors.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a9ac8613-339f-4b90-ab90-ec91f8d792c6/Samuel+Moed%2C+Director%2C+BiondVax+Pharmaceuticals+%28jpg%29.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bfb3e501-355a-4a38-a2a8-3ec9caece60d/Avner+Rotman_150x213.jpg
https://www.scinai.com/leadership-bios
daily
0.75
2023-07-09
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/292585a3-bd7c-4072-a1c2-a4e216f9c8ea/Amir+Reichman.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ad085348-d38a-4cae-9905-464e44ec0e2c/Tamar+Ben-Yedidia.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/11f64a8d-a4df-4532-b558-f9e67ad3837b/Elad+Mark.jpg
https://www.scinai.com/amir-reichman
daily
0.75
2024-03-25
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4136896e-8480-4cec-8725-b2e14a4b203a/amir.PNG
https://www.scinai.com/tamarbenyedidia
daily
0.75
2025-03-09
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c641f7d3-3b55-4239-8786-98deec5db321/Tamar.PNG
https://www.scinai.com/elad-mark
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6e0c62d0-93e3-4928-bd35-a7aa80c9c45e/Elad.PNG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://www.scinai.com/uri-ben-or
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/27dd0d5f-c12a-4bbd-a4fb-dea83791b82f/Uri_Ben_Or.png
https://www.scinai.com/dalit-weinstein-fischer
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d45403e0-e074-4040-a076-d97f4aa94e53/Dalit%2BWeinstein%2BFischer.jpg
https://www.scinai.com/tehila-sonnenfeld
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/2a84e7d2-b791-42e8-8582-fbd9169055ea/PXL_20230418_071406690.PORTRAIT%7E3-EDIT.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://www.scinai.com/oded-ovadia
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6395238f-0396-4f0a-8de8-fe39f04089c2/Oded+Ovadia.JPG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://www.scinai.com/joshua-philipson
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4f6b11ac-9b42-4393-a826-b83bbd6a203c/Joshua.PNG
https://www.scinai.com/merav-kamensky
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b850455c-a9ac-42ee-9bd9-0f2ea32c313c/Meav.PNG
https://www.scinai.com/naama-adi-hen
daily
0.75
2024-03-26
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e990922f-38ae-42dc-9a4e-44675966b557/Naama+Adi+Hen.JPG
https://www.scinai.com/privacy-policy
daily
0.75
2023-09-04
https://www.scinai.com/terms-of-use
daily
0.75
2023-10-31
https://www.scinai.com/financial
daily
0.75
2023-08-22
https://www.scinai.com/code-of-conduct
daily
0.75
2023-09-07
https://www.scinai.com/nominating-and-governance-committee-charter
daily
0.75
2023-09-07
https://www.scinai.com/compensation-committee-charter
daily
0.75
2023-09-07
https://www.scinai.com/audit-committee-charter
daily
0.75
2023-09-07
https://www.scinai.com/mark-germain
daily
0.75
2023-09-03
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ddfbfd59-c226-4bfe-b537-3f9259e38140/Mark+Germain%2C+BiondVax+Chairman+of+the+Board+of+Directors.jpg
https://www.scinai.com/jay-green
daily
0.75
2023-08-30
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/41a75c69-c44c-44f5-9841-ff89da6d1ffa/Jay+Green%2C+member+of+BiondVax%27s+Board+of+Directors_150x213.jpg
https://www.scinai.com/morris-laster
daily
0.75
2023-08-30
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/77cd5f37-e9c3-4100-ace0-025b13fa678a/Morris+Laster_150x213.jpg
https://www.scinai.com/yael-margolin
daily
0.75
2023-08-30
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6dcc207c-ef55-4ffb-ac2f-c4843ba33ad8/Yael+Marolin.jpg
https://www.scinai.com/sam-moed
daily
0.75
2023-08-30
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a9ac8613-339f-4b90-ab90-ec91f8d792c6/Samuel+Moed%2C+Director%2C+BiondVax+Pharmaceuticals+%28jpg%29.jpg
https://www.scinai.com/adi-raviv
daily
0.75
2023-08-30
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/06d57f9d-dcb7-458a-b629-48ec817bc8fd/Adi+Raviv+-+BiondVax_opt.jpg
https://www.scinai.com/avner-rotman
daily
0.75
2023-09-03
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bfb3e501-355a-4a38-a2a8-3ec9caece60d/Avner+Rotman_150x213.jpg
https://www.scinai.com/alona-tal
daily
0.75
2025-03-06
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ed480d6e-480c-4b25-b9c0-66183aded806/Alona+Tal.png
https://www.scinai.com/contact
daily
0.75
2025-01-19
https://www.scinai.com/404
daily
0.75
2023-09-04
https://www.scinai.com/biondvax-is-now-scinai
daily
0.75
2023-09-06
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/379a3c37-49bb-41d2-81a9-77444a83c825/SCINAI+LOGO+WHITE.png
https://www.scinai.com/boutique-cdmo
daily
0.75
2024-03-10
https://www.scinai.com/scinai-cdmo-at-bio-europe-spring-2024
daily
0.75
2024-03-12
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/912b6716-2020-459b-bd95-809b19dfd83f/BIO-Europe+Spring+24_Logo+stacked+KO+Dates%403x.png
https://www.scinai.com/solomon-gahtan
daily
0.75
2025-03-05
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e21e5c85-41d5-4ee3-8fb7-69053b8466b2/Solomon+Gahtan.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e3ba3dd9-6422-4a85-a473-f63c14e346b3/107149_gray_circle_linkedin_icon.png
https://www.scinai.com/home-1
daily
1.0
2025-01-19
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d45403e0-e074-4040-a076-d97f4aa94e53/Dalit%2BWeinstein%2BFischer.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4136896e-8480-4cec-8725-b2e14a4b203a/amir.PNG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c641f7d3-3b55-4239-8786-98deec5db321/Tamar.PNG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e428bfd9-4198-4379-86de-f4daad043ef0/Elad.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/59dc125a-9a29-4816-bd90-b8749d579cea/alpaca_lab+copy.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/10c36d2e-56c2-4081-a35e-d05e38850e63/02.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bf980033-107a-426e-98f2-b09072ea4ec5/01.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/1646f3f3-bbb4-4d36-9d27-99e3235e1e14/04.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/152c4b69-e81a-4489-82bc-3473e207448c/03.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/81e28cad-0135-4fa1-aefa-4eca650df375/rsz_1matthias_dobbelstein.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/23fa6ca3-de3b-4271-a9f2-00541a3f1014/Dirk+Goerlich.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/7343edc0-3ea1-4a93-b714-bc4670fd86e7/image+%285%29.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bbb9b290-4646-4bfa-8a6f-8a7d942d6e37/Aseptic+fill+and+finish.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/929c8ad5-5602-4e36-993b-aeae205468eb/image+%284%29.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ccf4dfa5-91b9-4a98-ad5b-a8e5734da207/P1054813.MOV.00_42_21_02.Still001.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/777f838b-c28a-4f0a-8bd6-829922906f6d/04.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bc06b316-cbb3-47e8-9042-546ef5b67bc1/02.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/34d2cff7-0baf-4b5c-978e-aa853ca61754/articles_preview_04.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d8af3818-5f9f-4d71-baca-a6a0f3b6f03b/articles_preview_03.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3fcde8b9-d917-40a7-885e-56012d857fb5/voyager_suture.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8f8d103f-0024-440f-909e-c627066a1d99/articles_preview_amir.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/60c6b9c1-55a1-46f3-ba2c-dc0d958fb5c9/articles_preview_science_direct.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/596ad921-1c59-424f-ade6-83f266a00b68/Expert_panel.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8b19f146-d4ef-4e34-9659-979482a9078f/serpin.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b4a57457-37e6-4da9-b1ca-d37c3ee280a3/hopec.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/90f13d78-f8b5-4010-968e-48e781fa8cb0/US.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/17b23f09-48aa-406f-b542-07022c450868/welcome.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bc88bc55-5483-430b-bf04-04b2d5c23b59/01_Scinai_banner_mountain_b.jpg
Home Moran
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/78c06e67-a0be-4d3b-98e7-a8292c24725b/03_Scinai_banner_Lab.jpg
Home Moran
https://www.scinai.com/dermatology-summit-presentation
daily
0.75
2024-07-16
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8e642106-35c8-43c0-9900-f979027984de/image+%281%29.png
https://www.scinai.com/cdmo
daily
0.75
2025-02-24
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9cec8d7f-80f1-4446-8cba-5d68d208111c/image+%284%29.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c66dc538-912c-46d6-94a3-6254c7e6222f/PXL_20230430_141523787.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/80db79ec-22c9-407d-86c9-8a1d367dfb69/Aseptic+fill+and+finish.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8f2befbf-babb-41ac-ba6f-c5f012abcb24/PXL_20230430_140855792.MP+%281%29.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e2e30a63-463d-4f54-92e7-82c095da98c0/20%2B+years+of+experience_2.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/53326586-8a05-4b66-bf03-3ca213aadf8f/State+of+the+art+laboratories.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/5ffeb17f-6888-4339-ae94-9cd7f5b48031/Pre-clinical+to+phase+III.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/659aca52-e3d3-4424-aa69-9fe930217e4b/Pre-clinical+to+phase+III_2.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/777f838b-c28a-4f0a-8bd6-829922906f6d/04.jpg
Comprehensive Biologics CDMO Services
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3fcde8b9-d917-40a7-885e-56012d857fb5/voyager_suture.jpg
Comprehensive Biologics CDMO Services
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/bc06b316-cbb3-47e8-9042-546ef5b67bc1/02.jpg
Comprehensive Biologics CDMO Services
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8b19f146-d4ef-4e34-9659-979482a9078f/serpin.jpg
Comprehensive Biologics CDMO Services
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b4a57457-37e6-4da9-b1ca-d37c3ee280a3/hopec.jpg
Comprehensive Biologics CDMO Services
https://www.scinai.com/cdmo-process-development
daily
0.75
2024-10-08
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/de54044a-091d-43d1-8e4a-ed3f8c49e5a5/process_2.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6af39fde-87c2-4084-9da1-2c6339b6c428/process_4.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/80ea6d33-5fe7-401e-bbfa-987a345bf957/process_1.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/3bd471b6-ee8c-4303-ad7f-c0395e9fcf2c/process_3.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/038ff144-bee3-4ec9-8cda-1397d635d144/Zohar+Gadri.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/cd68a37a-4c18-44c6-a44b-80c55dd90fa6/IMG_20220703_100939083_PORTRAIT.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f725cd17-8a6d-4c19-8b0e-f937554fb52a/IS1_0494.jpg
https://www.scinai.com/shareholders
daily
0.75
2024-10-16
https://www.scinai.com/cdmo-process-development-1
daily
0.75
2024-07-14
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/038ff144-bee3-4ec9-8cda-1397d635d144/Zohar+Gadri.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/f725cd17-8a6d-4c19-8b0e-f937554fb52a/IS1_0494.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/cd68a37a-4c18-44c6-a44b-80c55dd90fa6/IMG_20220703_100939083_PORTRAIT.jpg
https://www.scinai.com/cdmo-analytical-methods-development
daily
0.75
2024-08-04
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/44c9d67d-e3ee-4150-8621-319755f33a7b/Spectrophotometry.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/02249b5f-3f30-4a60-93c6-a3d02b11c41a/Physicochemical+methods.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/27387ebf-e42e-4979-94e6-dc57e99d5290/Merav+Kamensky+-+sq.JPG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/6395238f-0396-4f0a-8de8-fe39f04089c2/Oded+Ovadia.JPG
https://www.scinai.com/cgmp-manufacturing
daily
0.75
2024-12-19
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d99ee968-3fc1-47bf-9c0b-b8f00092d375/Downstream.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/8ceb68e5-c0b5-4e17-bf7d-585fd7156fd3/Media+and+buffer+preparation.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/487a2a69-50ae-4d94-9606-81a09576bdbd/Upstream.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/442d90e6-6058-4120-90a7-2b1ced9648d5/PXL_20230418_071406690.PORTRAIT%7E2.jpg
https://www.scinai.com/aseptic-processing
daily
0.75
2024-08-04
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/9aae382b-7be5-4b3c-82df-4056bdd46152/Fully+equipped.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/77ba91b2-3e82-4c3a-b9b0-89a15a81e30a/Grade+A+Filling+Machine.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/442d90e6-6058-4120-90a7-2b1ced9648d5/PXL_20230418_071406690.PORTRAIT%7E2.jpg
https://www.scinai.com/quality-and-regulatory-standards
daily
0.75
2024-08-04
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/221a9a8d-3f1b-4270-aaca-dd3da588cfff/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d1f01ac1-013d-46a0-abf8-f94f1ddd5fc0/Quality+Management.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/79ec2952-e438-46d3-9792-bb995799683f/CMC+Support.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/e990922f-38ae-42dc-9a4e-44675966b557/Naama+Adi+Hen.JPG
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c9e802c7-7bf0-41f5-8ae9-3049f8618b18/IS1_0590.JPG
https://www.scinai.com/invivo-study
daily
0.75
2024-07-16
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ea879cb0-8738-4d37-9261-ed8e5c18847c/Secukinumab.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/30b68f36-1c44-4d23-8fa8-6f4c49066eb5/negative+control+.jpg
https://www.scinai.com/bioservices
daily
0.75
2025-02-02
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/72a2126e-9c4e-43b7-a1df-1b3905379b93/checked.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c6b454c1-3ebe-4680-b9b2-e14d8e1d030f/Image.png
https://www.scinai.com/cdmo-lp-catalog
daily
0.75
2024-07-16
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/72a2126e-9c4e-43b7-a1df-1b3905379b93/checked.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/c6b454c1-3ebe-4680-b9b2-e14d8e1d030f/Image.png
https://www.scinai.com/investorsrelations
daily
0.75
2025-03-13
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/dbb5d825-3816-43f7-a35b-a6aa8506da50/ppt.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b10a4f58-8f5f-4c6a-8455-de1385315059/down-right-arrow.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/975952e6-ccaa-4328-a27c-116d33c57648/event_banner.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a18db0a3-fd78-4f69-87ed-9656e8b877d3/SEC+icon_2.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/94360763-e318-4686-be75-6bf056243bbf/online-video.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/aa198e21-05ff-4de6-9e88-c3de016fdf02/pdf.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/b4d3caa0-1a4a-487c-b3e2-74022337e42b/public-relation.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/d5f88bcf-fc25-4233-bac2-63bd36997004/site.jpg
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/a2200924-8191-4a72-b349-43ca9754a374/presentation+%282%29.png
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/4147ab14-942e-4bb2-8145-d9e2aab21a21/bar-graph.png
https://www.scinai.com/cdmo-lp-ebook
daily
0.75
2024-08-13
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/38952b6b-06ee-44e1-a176-896d384bef0a/ebook.png
https://www.scinai.com/team2
daily
0.75
2023-07-02
https://www.scinai.com/team2/tamar-ben-yedidia2
monthly
0.5
2023-07-02
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/ad085348-d38a-4cae-9905-464e44ec0e2c/Tamar+Ben-Yedidia.jpg
https://www.scinai.com/team2/amir-reichman
monthly
0.5
2023-07-02
https://images.squarespace-cdn.com/content/v1/6422f142b82fea6c2b59c10b/292585a3-bd7c-4072-a1c2-a4e216f9c8ea/Amir+Reichman.jpg